Navigation Links
Patient-Centered Outcomes Research Institute announces 2 awards to Group Health
Date:12/27/2012

Seattle, WAGroup Health has been approved for two research awards from the Patient-Centered Outcomes Research Institute (PCORI) to study ways to improve care for back pain and to connect patients with community resources. The projects are part of a portfolio of patient-centered comparative clinical effectiveness research that addresses PCORI's National Priorities for Research and Research Agenda.

Authorized by the Affordable Care Act, PCORI is an independent nonprofit dedicated to funding comparative clinical effectiveness research. In its first cycle of funding, with 25 projects approved nationwide, PCORI awarded two to Washington state, both to Group Health, a "learning health system" where research and care delivery inform each other:

Group Health Research Institute (GHRI) Senior Investigator Dan Cherkin, PhD, will lead a project on back pain, which is an extremely common condition. The project will develop and test a tool for finding out which patients are at risk for long-term back pain and which evidence-based treatments are most likely to help them based on their levels of risk. The tool will be based on one that was developed and found effective in England for tailoring treatment type and intensity to the needs of each individual patient with back pain. Many health care systems have expressed interest in using this tool in the United States, but Group Health will be the first to do so. Patients and health care providers will be involved in adapting the tool to be user-friendlyand will test and evaluate it in Group Health primary care clinics. Dr. Cherkin also directs Bastyr University Research Institute. His collaborators on this project will be Group Health Assistant Medical Director Martin Levine, MD; Research Associate Clarissa Hsu, PhD; Associate Investigator Andrea Cook, PhD; Senior Investigator Karen Sherman, PhD, MPH; and Research Associate Ben Balderson, PhD. Other significant contributors will be Group Health Director of Strat
'/>"/>

Contact: Rebecca Hughes
hughes.r@ghc.org
206-287-2055
Group Health Research Institute
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. The price tag on a patient-centered medical home
2. Ability to metabolize tamoxifen affects breast cancer outcomes, Mayo Clinic-led study confirms
3. Renaissance Physician Organization Leading Effort with Greater Houston Healthconnect to Enhance Care Coordination and Patient Outcomes
4. Lifestyle changes linked to better outcomes after peripheral intervention
5. Palliative care improves outcomes for seniors
6. New stem cell research, transplant strategies show promise to improve outcomes, reduce complications
7. Studies challenge standards to improve treatment outcomes for patients with clotting disorders
8. Studies assess genetics, modified treatment to improve outcomes, reduce toxicity
9. The effect of treating institution on outcomes in head and neck cancer
10. New tumor tracking technique may improve outcomes for lung cancer patients
11. First-of-its-kind program improves outcomes for seniors admitted for trauma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Patient-Centered Outcomes Research Institute announces 2 awards to Group Health
(Date:12/24/2014)... Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) ... currently underway in Pennsylvania’s Philadelphia Court of Common Pleas, ... 2014, court documents indicate that 1,183 claims had been ... developed gynecomastia (male breast growth) and other complications allegedly ... that this represents an increase of more than 100 ...
(Date:12/24/2014)... Dr. Vu Ho, a Dallas based facial plastic ... med-spa with the addition of new Silk Peel skin ... and services. , “Silk Peel is a procedure that ... “As a result it can address issues like acne ... or blemishes.” , Similar to microdermabrasion, Silk Peel ...
(Date:12/24/2014)... December 25, 2014 Today, UWDress.com, the famous ... sleeve wedding gowns, and launched a site-wide wedding gown promotion. ... sleeve wedding gowns in a more unexpected way, the collection ... are popular in the global market, and they are available ... UWDress.com are offered at discounted prices, up to 75% off; ...
(Date:12/24/2014)... The report “Stivarga (Colorectal Cancer) – ... current treatment landscape, unmet needs, current pipeline and commercial ... drug which is used in the treatment of colon ... is also prescribed to patients who suffer from advanced ... is a multi-kinase inhibitor and it blocks many enzymes ...
(Date:12/24/2014)... BambooIndustry.com a famous bamboo flooring company ... the company announces its multiple layer bamboo panel ... these new products. , Bamboo panel is the product ... layer bamboo panel board features high quality selective bamboo ... free. The bamboo panel consists of multiple layers of ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Buy Cheap Long Sleeve Wedding Gowns At UWDress.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Bamboo Flooring Company Bambooindustry.com Introduces Its Multiple Layer Bamboo Panel Board Collection 2
... be crumbling under the mounting pressure of dengue. Safdarjung ... several patients being referred to AIIMS and the Red ... patients are given platelets only on the condition of ... exchange for the required platelets. Dr Santosh at the ...
... come up with some valuable information which would definitely ... the mind of an autistic person is blue printed. ... to be affected by autism a developmental disorder typically ... people. ,Lead researcher Dr Michael Murias, from ...
... disorders in women may be diagnosed by examining hair ... It is usually difficult to diagnose eating disorders//, as ... they try to hide it. ,The study ... University (BYU) in U.S. is published in the Rapid ...
... has made a formal application to the European Medicines ... as a viable treatment// for advanced HER2-positive and hormone ... received from the international TAnDEM study which showed that ... from 2.4 months to 4.8 months. ,HER2-positive breast ...
... by NHS hospitals because they are serving meals that are ... catering at 97 health trusts. ,The survey revealed ... food brought in by relatives and friends. Over 37% of ... or tasted disgusting. ,Over a fifth of patients claimed that ...
... John Howard ,the prime minister of Australia, stirred up the ... media for the first time that she had battled ... the National Breast Cancer Centre, she was addressing an august ... all important national breast cancer report.,Over the ‘Pink Ribbon’ breakfast ...
Cached Medicine News:Health News:Mounting Pressure of Dengue in Delhi Hospitals 2Health News:Eating Disorders may be diagnosed by Hair analysis 2Health News:NHS Food Slowing Patient Recovery 2
(Date:12/24/2014)... Va. , Dec. 23, 2014  The ... diastolic blood pressure target for people with diabetes ... moderate or high doses of statins, in keeping ... management enacted by the American College of Cardiology ... are reflected in the most recent changes to ...
(Date:12/24/2014)... CHAPEL HILL, N.C. , Dec. 23, 2014 /PRNewswire/ ... marketplace success. As the key link between the medical ... will grow even more in the coming years as ... relationships. According to research by benchmarking ... and MSLs can gain an important edge is by ...
(Date:12/22/2014)... DUBLIN , Dec. 22, 2014 Research and ... addition of the "US Self-monitoring Blood Glucose Market" ... http://photos.prnewswire.com/prnh/20130307/600769 This market insight focuses ... in the United States . Reimbursement ... studied. Thorough product analyses for more than 73 SMBG ...
Breaking Medicine Technology:New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4Role of Medical Science Liaisons Evolving in Medical Device Sector 2US Self-monitoring Blood Glucose Market 2
... MIVI-TRUST Phase III Program, Confirming... -- LEUVEN, Belgium, September 6, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... China, Sept. 3 /PRNewswire-Asia-FirstCall/ -- ... ... var ... by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
Cached Medicine Technology:ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 2ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 3ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 4ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 5ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 6ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 7ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 8ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 9ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders 10China Sky One Medical Updates Financial Guidance for 2010 2China Sky One Medical Updates Financial Guidance for 2010 3China Sky One Medical Updates Financial Guidance for 2010 4China Sky One Medical Updates Financial Guidance for 2010 5China Sky One Medical Updates Financial Guidance for 2010 6China Sky One Medical Updates Financial Guidance for 2010 7China Sky One Medical Updates Financial Guidance for 2010 8
... chemiluminescence assay for the measurement ... serum. Growth Hormone (GH) is ... the anterior pituitary gland under ... hormone releasing hormone (GHRH) and ...
... the sulfate ester of DHEA, derived from ... DHEA in adrenal and extradrenal tissues. DHEA ... the adrenal cortex, and is a precursor ... relatively weak androgenic activity, which for unsulfated ...
... The DHEA-S ELISA kit is based ... separation. An unknown amount of DHEA-S present ... of DHEA-S conjugated with horse-radish peroxidase compete ... DHEA-S antiserum coated onto the wells. After ...
EL-RF-IgM is high sensitivity quantitative rheumatoid factor IgM....
Medicine Products: